Literature DB >> 10764210

NG, NG-dimethylarginine and NG, NG-dimethylarginine in renal insufficiency.

M Al Banchaabouchi1, B Marescau, I Possemiers, R D'Hooge, O Levillain, P P De Deyn.   

Abstract

Asymmetric NG,NG-dimethylarginine (ADMA) and symmetric NG,NG-dimethylarginine (SDMA) are basic endogenous amino acids with a guanidino group. Our renal distribution study of dimethylarginines clearly indicates that, in mouse and rat, ADMA and SDMA levels are most abundant as protein-incorporated compounds (95%). ADMA represents almost 90% of this protein-incorporated dimethylarginine amount. The four zones studied (cortex, outer and inner stripe of outer medulla, inner medulla) contain more or less the same amount of protein-incorporated dimethylarginine; the concentrations of both free dimethylarginines vary more in the different zones. Plasma and urinary excretion levels in Man, rat and mouse were determined, their changes in renal insufficiency were examined and compared between species. Highly significant negative correlations between both plasma dimethylarginine levels and creatinine clearances were found in Man and rat. The correlation between urinary ADMA excretion levels and creatinine clearances was highly significant and positive in Man and mouse; however, in rat the correlation was negative. In patients with severe renal insufficiency, ADMA clearance was only 9.5% of controls, and that of SDMA only 7.8%. Clearance of ADMA and SDMA in nephrectomized mice was 60.5% and 53.8% of controls, respectively, whereas in nephrectomized rat, ADMA clearance actually increased 5.4 times and that of SDMA did not change significantly. Man, rat and mouse show similarities as well as differences in metabolism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764210     DOI: 10.1007/s004249900220

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  14 in total

1.  Simultaneous bioanalysis of L-arginine, L-citrulline, and dimethylarginines by LC-MS/MS.

Authors:  Soyoung Shin; Sun-Mi Fung; Srinidi Mohan; Ho-Leung Fung
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-01-14       Impact factor: 3.205

2.  Transjugular intrahepatic portosystemic shunt-placement increases arginine/asymmetric dimethylarginine ratio in cirrhotic patients.

Authors:  Michiel P C Siroen; Reiner Wiest; Milan C Richir; Tom Teerlink; Jan A Rauwerda; Friedrich T Drescher; Niels Zorger; Paul A M van Leeuwen
Journal:  World J Gastroenterol       Date:  2008-12-21       Impact factor: 5.742

Review 3.  The role of asymmetric and symmetric dimethylarginines in renal disease.

Authors:  Edzard Schwedhelm; Rainer H Böger
Journal:  Nat Rev Nephrol       Date:  2011-03-29       Impact factor: 28.314

4.  Dimethylarginines in chronic renal failure.

Authors:  N Wahbi; R N Dalton; C Turner; M Denton; I Abbs; R Swaminathan
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

5.  Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis.

Authors:  Yildiz Oner-Iyidogan; Pernur Oner; Hikmet Kocak; Figen Gurdol; Seldag Bekpinar; Yesim Unlucerci; Yasar Caliskan; Pinar Cetinalp-Demircan; Taner Kocak; Aydin Turkmen
Journal:  Clin Exp Med       Date:  2009-02-24       Impact factor: 3.984

6.  Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity.

Authors:  Raf Brouns; Bart Marescau; Ilse Possemiers; Rishi Sheorajpanday; Peter P De Deyn
Journal:  Neurochem Res       Date:  2009-03-19       Impact factor: 3.996

Review 7.  Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.

Authors:  Paloma Lluch; Gloria Segarra; Pascual Medina
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 8.  Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review.

Authors:  Johannes Jacobi; Philip S Tsao
Journal:  Am J Nephrol       Date:  2007-10-24       Impact factor: 3.754

9.  Methylated arginine derivatives in children and adolescents with chronic kidney disease.

Authors:  Ellen R Brooks; Craig B Langman; Sihe Wang; Heather E Price; Abigail L Hodges; Lara Darling; Amy Z Yang; Frederick A Smith
Journal:  Pediatr Nephrol       Date:  2008-10-02       Impact factor: 3.714

Review 10.  Cellular ADMA: regulation and action.

Authors:  Tom Teerlink; Zaiming Luo; Fredrik Palm; Christopher S Wilcox
Journal:  Pharmacol Res       Date:  2009-08-12       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.